Co. Ltd. patents describe molecular glue degraders reported to be useful for the treatment of cancer, anemia, liver failure, diabetes, infections, sarcoidosis, autoimmune diseases and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback